Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Prince Court Medical Centre employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2007, the MSQH accredited hospital is located in Kuala Lumpur, Malaysia and has 277 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
Delhi, India
The BLK-Max Super Speciality Hospital is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 1959, the JCI, NABHcertified hospital is situated in Delhi, India, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 650.
CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.
Kings College Hospital Dubai has advanced infrastructure for cellular therapy and provides CAR T-cell therapy to patients with specific types of blood cancers. The JCI accredited establishment of the year 2019 is situated in Dubai, United Arab Emirates, and contains 100 beds.
CAR-T therapy is a form of immunotherapy in which the patient's immune system is engineered to target and destroy cancerous cells. The execution of the therapy involves cell collection, laboratory enhancement processes, chemotherapy, and infusion. Patients are monitored carefully before, during, and after treatment, as they may experience immune-related complications.
The Parkway Pantai is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 1974, the JCI, MSQHcertified hospital is situated in Kuala Lumpur, Malaysia, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 499.
CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.
Artemis Health Institute has advanced infrastructure for cellular therapy and provides CAR T-cell therapy to patients with specific types of blood cancers. The JCI, NABH accredited establishment of the year 2007 is situated in Gurgaon, India, and contains 750 beds.
CAR-T therapy is a form of immunotherapy in which the patient's immune system is engineered to target and destroy cancerous cells. The execution of the therapy involves cell collection, laboratory enhancement processes, chemotherapy, and infusion. Patients are monitored carefully before, during, and after treatment, as they may experience immune-related complications.
Sunway Medical Centre employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 1999, the ACHS accredited hospital is located in Kuala Lumpur, Malaysia and has 724 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
Bangpakok 9 International Hospital has advanced infrastructure for cellular therapy and provides CAR T-cell therapy to patients with specific types of blood cancers. The JCI, GHA accredited establishment of the year 2003 is situated in Bangkok, Thailand, and contains 300 beds.
CAR-T therapy is a form of immunotherapy in which the patient's immune system is engineered to target and destroy cancerous cells. The execution of the therapy involves cell collection, laboratory enhancement processes, chemotherapy, and infusion. Patients are monitored carefully before, during, and after treatment, as they may experience immune-related complications.
Medipol Bahçelievler Hospital employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2022, the JCI accredited hospital is located in Istanbul, Turkey and has 441 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
Medanta - The Medicity employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2009, the JCI, NABH accredited hospital is located in Gurgaon, India and has 1250 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
ParkCity Medical Centre has advanced infrastructure for cellular therapy and provides CAR T-cell therapy to patients with specific types of blood cancers. The JCI accredited establishment of the year 2012 is situated in Kuala Lumpur, Malaysia, and contains 300 beds.
CAR-T therapy is a form of immunotherapy in which the patient's immune system is engineered to target and destroy cancerous cells. The execution of the therapy involves cell collection, laboratory enhancement processes, chemotherapy, and infusion. Patients are monitored carefully before, during, and after treatment, as they may experience immune-related complications.
The Gleneagles Hospital Mumbai is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 1996, the JCIcertified hospital is situated in Mumbai, India, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 450.
CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.
The Subang Jaya Medical Centre is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 1985, the JCIcertified hospital is situated in Kuala Lumpur, Malaysia, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 442.
CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.
Ghaziabad, India
Max Super Specialty Hospital, Vaishali employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2008, the NABL, NABH accredited hospital is located in Ghaziabad, India and has 370 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
Max Hospital, Gurgaon has advanced infrastructure for cellular therapy and provides CAR T-cell therapy to patients with specific types of blood cancers. The ISO, NABH, NABL accredited establishment of the year 2007 is situated in Gurgaon, India, and contains 104 beds.
CAR-T therapy is a form of immunotherapy in which the patient's immune system is engineered to target and destroy cancerous cells. The execution of the therapy involves cell collection, laboratory enhancement processes, chemotherapy, and infusion. Patients are monitored carefully before, during, and after treatment, as they may experience immune-related complications.
Fortis Escorts Heart Institute, Okhla employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 1988, the NABL accredited hospital is located in Delhi, India and has 310 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
| Speciality | Oncology |
| Procedure | CAR-T |
| Success Rate | Varies as per stage, grade, type and location of cancer |
| Recovery Time | Few days to several weeks |
| Treatment Time | Several weeks or even months |
| Chances of Recurrence | Varies as per stage, grade, type and location of cancer |
Leukaemia is a blood disease that arises from the bone marrow and produces white blood cells. Many patients recover from chemotherapy, targeted therapy, or stem cell transplantation,
